Phase 1 Advanced Solid Tumor Clinical Trials

Phase 1 Advanced Solid Tumor Research Landscape

There are 3 Phase 1 clinical trials for Advanced Solid Tumor tracked on ReadTheTrial. This represents 50% of all 6 Advanced Solid Tumor trials.

Phase 1 trials for Advanced Solid Tumor represent a critical early-stage segment of the research pipeline. Currently, 2 of these trials are actively recruiting participants.

Phase 1 Trials

Recruiting

Trial Status Distribution

RECRUITING: 2 trials
TERMINATED: 1 trial

Phase 1 Advanced Solid Tumor Trials

A Phase 1, First-in-human, Multicentre, Open-label, Dose Escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037 · RECRUITING · Phase 1

A Phase 1a/1b Dose Escalation, Dose Expansion Study of SW-682 in Participants With Advanced Solid Tumors Enriched for Those With Hippo Pathway Mutations

NCT06251310 · RECRUITING · Phase 1

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

NCT06130254 · TERMINATED · Phase 1

Frequently Asked Questions

What are Phase 1 Advanced Solid Tumor clinical trials?

Phase 1 trials for Advanced Solid Tumor are clinical studies at this specific development stage. There are currently 3 such trials tracked on ReadTheTrial.

How can I join a Phase 1 Advanced Solid Tumor trial?

Review the individual trial pages for eligibility criteria and recruiting status. Currently 2 Phase 1 Advanced Solid Tumor trials are recruiting. Discuss participation with your doctor.

Who sponsors Phase 1 Advanced Solid Tumor trials?

Multiple organizations sponsor these trials.